By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mylan Laboratories Inc. 

1500 Corporate Drive
Suite 400
Canonsburg  Pennsylvania  15317  U.S.A.
Phone: 724-514-1800 Fax: n/a



Company News
Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable Court Ruling in AZILECT® Patent Infringement Litigation Against Mylan Laboratories Inc. (MYL) 9/23/2013 10:02:20 AM
Mylan Laboratories Inc. (MYL) Launches Generic Version of Revatio® Tablets 11/13/2012 10:13:55 AM
Mylan Laboratories Inc. (MYL)'s Combination Drug Gets Tentative FDA Approval Under PEPFAR 2/23/2012 7:44:37 AM
Matrix Laboratories Limited (MAXL.BO) Completes Name Change to Mylan Laboratories Inc. (MYL) 10/19/2011 11:35:30 AM
Mylan Laboratories Inc. (MYL) Receives Approval for Generic Version of Effexor XR(R) Capsules 6/2/2011 10:38:30 AM
Mylan Laboratories Inc. (MYL) Receives Approval for Nabumetone Tablets 7/14/2010 11:28:17 AM
Mylan Laboratories Inc. (MYL) Declares Quarterly Preferred Stock Dividend 8/1/2008 10:44:13 AM
Mylan Laboratories Inc. (MYL) Confirms Patent Challenge Relating to Azor(R) 6/4/2008 2:32:58 PM
Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA (MKGAF.PK) 6/2/2008 7:19:00 AM
Mylan Laboratories Inc. (MYL) Reports Adjusted Diluted EPS of $0.09 for the Quarter Ended March 31, 2008 5/9/2008 11:13:44 AM